Navigation Links
Video: American Dental Association Statement: Food and Drug Administration Action on Dental Amalgam
Date:7/28/2009

WASHINGTON, July 28 /PRNewswire/ -- The American Dental Association (ADA) agrees with the U.S. Food and Drug Administration's (FDA) decision not to place any restriction on the use of dental amalgam, a commonly used cavity-filling material.

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/ada/39331/

The FDA ruling issued today categorizes encapsulated dental amalgam as a class II medical device, placing it in the same class as gold and tooth-colored composite fillings. The ADA has supported a class II designation for dental amalgam since 2002, when first proposed by the FDA.

"The FDA has left the decision about dental treatment right where it needs to be -- between the dentist and the patient," states ADA President Dr. John Findley. "This decision underscores what the ADA has long supported -- a discussion between dentists and patients about the full range of treatment options to help patients make educated decisions regarding their dental care."

Dental amalgam is a cavity-filling material made by combining mercury with other metals such as silver, copper and tin. Numerous scientific studies conducted over the past several decades, including two large clinical trials published in the April 2006 Journal of the American Medical Association, indicate dental amalgam is a safe, effective cavity-filling material for children and others. And, in its 2009 review of the scientific literature on amalgam safety, the ADA's Council on Scientific Affairs reaffirmed that the scientific evidence continues to support amalgam as a valuable, viable and safe choice for dental patients.

"Dentists are doctors specializing in oral health care," Dr. Findley states. "We encourage people to
'/>"/>

SOURCE American Dental Association
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Video: Sodexo Takes on Childhood Obesity in School Cafeterias
2. Video: What Are Those Little Red Bumps?
3. Video: Perot Systems Unveils Series of Healthcare Video Case Studies
4. Video: FDA Approves Hologics Adiana(R) Permanent Contraception System
5. Video: New Online Film Introduces Longevinex Advantage(TM) -- The First Resveratrol-Based Dietary Supplement to Address Both Cellular and Connective Tissue Aging
6. Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment
7. Video: Gabrielle Reece Shows Natural is Beautiful in New PureVia(TM) Campaign
8. Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas
9. VIDEO: Cancer Treatment Centers of America Selects Site in GA for Proposed Hospital Serving Patients in Southeast
10. Video: New Biological Therapy Ilaris(R) Approved in US to Treat Children and Adults with CAPS, a Serious Life-Long Auto-Inflammatory Disease
11. Video: BeautyScoop(R) Is a Trip to Your Nutritionist and Dermatologist in One Single Packet. Lauren Slayton, NYC Nutritionist & Owner of FoodTrainers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 Healthcare Solutions , ... Procura Management, today announced the appointment of Richard ... In this position, Leonardo will direct Healthcare Solutions’ ... strategic growth initiatives. , Recognized in the property ... Leonardo brings more than 20 years of experience ...
(Date:6/18/2013)... June 18, 2013 David Connett, DO, ... Family Medicine for the College of Osteopathic Medicine of ... has been elected president of the Osteopathic Medical ... Brown Jr. appointed Connett, a 1984 alumnus of COMP, ... recently elected Connett to the position during a conference ...
(Date:6/18/2013)... cells in the mammary gland appear to provide a ... in life, and the subsequent development of breast cancer, ... July 2013 issue of the journal Cancer Prevention ... be associated with an increased risk of certain types ... biology of social stress to cancer have been hard ...
(Date:6/18/2013)... a way to make phytosterol molecules from plants dispersible ... potentially opening the way to dramatic reductions in human ... new process and composition was issued on June 11. ... in animals are highly similar and when both are ... they mix in the gut of an animal, the ...
(Date:6/18/2013)... computer guided fitness training system using a person,s ... winners of the LeWeb,13 London Startup Competition, Europe,s ... startup company, Genetrainer, building on University of Bristol ... Pethica and Julian Gough, Professor of Bioinformatics in ... from over 350 startups to be one of ...
Breaking Medicine News(10 mins):Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4Health News:Brandeis scientist invents anti-cholesterol process 2
... , FRIDAY, Dec. 2 (HealthDay News) -- ... more than doubled in the United States between 1997 ... large increase of prescriptions written at outpatient clinics is ... Dorn, an assistant professor of medicine at the University ...
... University of Nevada, Reno and licensed through the University,s ... publication "Better World Report" for a remarkable second year ... advancement that has been licensed through IMMY, a diagnostics ... save the lives of hundreds of thousands of AIDS ...
... , FRIDAY, Dec. 2 (HealthDay News) -- Major depression and ... pregnant women and new mothers, a new study indicates. ... women are and what led up to these tragic events," ... medicine at the University of Michigan Medical School, said in ...
... The American Journal of Industrial Medicine recently published a ... at more than twice the rate of the general U.S. population ... the collapse of the WTC towers in 2001. Preliminary study results ... , Past studies have documented high rates of asthma symptoms among ...
... commercial stage private oncology company, has announced that prominent ... be the first to provide access to its Tumor ... of recurrent glioblastoma multiforme (GBM). GBM is a ... , The NovoTTF device, approved by the ...
... , FRIDAY, Dec. 2 (HealthDay News) -- ,Topical treatment ... be the first line of therapy for treating psoriasis ... from the National Psoriasis Foundation Medical Board based in ... because they cause no known adverse effects. Psoriasis, ...
Cached Medicine News:Health News:Depression, Partner Conflict Raise Suicide Risk for Pregnant Women, New Moms 2Health News:Asthma rates double for WTC first responders 2Health News:Asthma rates double for WTC first responders 3Health News:Novocure establishes initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields Therapy 2Health News:Novocure establishes initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields Therapy 3Health News:New Guidelines for Treating Psoriasis When Pregnant or Nursing 2
(Date:6/18/2013)... June 18, 2013 The board of directors ... ) has declared a dividend for the third quarter ... stock. The dividend is payable September ... of business on August 15, 2013. Lilly, ... of pharmaceutical products by applying the latest research from ...
(Date:6/18/2013)... Today, Wall Street Reports announced new research reports ... Management Associates Inc. (NYSE: HMA ), IDEXX Laboratories, ... ISIS ), and Trius Therapeutics Inc. (NASDAQ: TSRX). ... including full price targets, industry analysis and analyst ratings - ... Report On June 7, 2013, Gilead Sciences Inc. ...
(Date:6/18/2013)... And EMERYVILLE, Calif. , ... presented final results today from a Phase 2/3 ... capsules demonstrating a statistically significant improvement in levodopa-induced ... at week 8 versus placebo in the Unified ... extended-release formulation of amantadine intended for once-nightly administration ...
Breaking Medicine Technology:Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6
... , April 29, 2010 Albireo today,announced ... recent study,assessing the safety, tolerability and efficacy of A3309 ... compound for,the treatment of irritable bowel syndrome with constipation ... during the 2010,Digestive Disease Week (DDW) annual meeting being ...
... SALT LAKE CITY , April 28 Sonic Innovations, ... Administration (VA), is conducting ongoing training events for government clinicians.  The company ... in San Diego, California and April 25 through ... for May 3 through 5 in Salt Lake City, ...
Cached Medicine Technology:Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 2Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 3Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 4Albireo Announces Positive Results From a Study With A3309 in Patients With Chronic Constipation 5Sonic Innovations Conducts National Training Events for Government Clinicians 2Sonic Innovations Conducts National Training Events for Government Clinicians 3
Ocuvite® vitamin and mineral supplements contain 2 mg of Lutein 8 times more than the leading multivitamins. Ocuvite also contains vitamin antioxidants A, C and E, as well as the minerals zinc, ...
... take their eyes for granted. Like ... eyes need proper nutrition and care ... vision as you age. In fact, ... to maintaining and preserving eye health ...
... The herbal extracts, vitamins, minerals, ... increases circulation to ocular tissue, ... healthy function of the lens ... This formula is optimized to ...
Online Unity Interlaboratory QC Data Management...
Medicine Products: